Cargando…

Activin A: a novel urinary biomarker of renal impairment in multiple myeloma

Renal impairment (RI) is a common complication of multiple myeloma (MM) that significantly affects treatment efficacy and mortality. However, no useful biomarkers for early detection of renal damage in MM exist. Reports indicate that activin A, a multifunctional cytokine of the TGF-β superfamily, is...

Descripción completa

Detalles Bibliográficos
Autores principales: Iriuchishima, Hirono, Maeshima, Akito, Takahashi, Shunsuke, Ishizaki, Takuma, Yokohama, Akihiko, Tsukamoto, Norifumi, Saitoh, Takayuki, Murakami, Hirokazu, Handa, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542761/
https://www.ncbi.nlm.nih.gov/pubmed/31072919
http://dx.doi.org/10.1042/BSR20190206